The US approaches a new grim milestone in the epidemic…
About the author:
I am a scientist with 20+ years in the biotech industry. I currently work as a consultant with companies involved in developing molecular diagnostics platforms, including some of the key testing platforms used to detect the SarsCoV2 virus.
So I bring an insider’s perspective that is scientifically oriented but directed to a general audience trying to make sense of the conflicting stories surrounding the Covid pandemic.
To learn more: https://www.linkedin.com/in/dalewharrison/
If you found this article useful, please sign up by hitting the “Subscribe Now” button below or share it with a friend…
500,000
Dr Harrison,
I would be interested to hear your observations on the FLCCC paper on the effectiveness of Ivermectin in the prophylaxis and treatment of Covid-19, in both clinical trials and in real-world use of the drug including in populations of over 100 million (e.g. Uttar Pradesh). https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf.
Thank you in advance
Pat Caslin
It is worth looking into the flu statistics you are using: flu statistics are usually actually a mix of flu and pneumonia so the number of total flu deaths is actually a lot lower. https://aspe.hhs.gov/cdc-%E2%80%94-influenza-deaths-request-correction-rfc